臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"su k y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 101-125 of 249 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-12-02T02:33:12Z	FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression	Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; Su K.-Y.; Chen H.-Y.; Lin C.-Y.; Chen J.-S.; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; PAN-CHYR YANG; Yu S.-L.
臺大學術典藏	2020-12-02T02:33:10Z	Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma	Su K.-Y.;Tseng J.-S.;Liao K.-M.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Pan-Chyr Yang;Yu S.-L.;Chang G.-C.; Su K.-Y.; Tseng J.-S.; Liao K.-M.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; PAN-CHYR YANG; Yu S.-L.; Chang G.-C.
臺大學術典藏	2020-12-02T02:33:03Z	Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression	Chen Y.-J.; Roumeliotis T.I.; Chang Y.-H.; Chen C.-T.; Han C.-L.; Lin M.-H.; Chen H.-W.; Chang G.-C.; Chang Y.-L.; Wu C.-T.; Lin M.-W.; Hsieh M.-S.; Wang Y.-T.; Chen Y.-R.; Jonassen I.; Ghavidel F.Z.; Lin Z.-S.; Lin K.-T.; Chen C.-W.; Sheu P.-Y.; Hung C.-T.; Huang K.-C.; Yang H.-C.; Lin P.-Y.; Yen T.-C.; Lin Y.-W.; Wang J.-H.; Raghav L.; Lin C.-Y.; Chen Y.-S.; Wu P.-S.; Lai C.-T.; Weng S.-H.; Su K.-Y.; Chang W.-H.; Tsai P.-Y.; Robles A.I.; Rodriguez H.; Hsiao Y.-J.; Chang W.-H.; Sung T.-Y.; Chen J.-S.; Yu S.-L.; Choudhary J.S.; Chen H.-Y.; PAN-CHYR YANG; Chen Y.-J.
臺大學術典藏	2020-11-04T01:59:23Z	R26R-GR: A Cre-Activable Dual Fluorescent Protein Reporter Mouse	Lin S.-W.; Yu I.-S.; Nicolis S.K.; Chien C.-L.; Favaro R.; Jang C.-W.; Behringer R.R.; Su I.-C.; Su K.-Y.; Hsu Y.-C.; Lin C.-C.; Wang W.-L.; Yen S.-T.; Hong J.-B.; Fan H.-H.; Chou F.-J.; Huang C.-Y.; YOU-TZUNG CHEN; Tsai M.-S.; Yang T.-L.; Ku A.T.; Huang K.-H.
臺大學術典藏	2020-08-13T06:34:04Z	Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory	Lin S.-W.; JIN-YUAN SHIH; Lin Y.-L.; Hsueh Y.-P.; Yang P.-C.; Huang P.-H.; Lin S.-R.; Huang H.-P.; Yu I.-S.; Fu W.-M.; Chien W.-L.; Su K.-Y.
臺大學術典藏	2020-08-13T06:33:54Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏	2020-08-13T06:33:51Z	Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations	Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; JIN-YUAN SHIH; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Yang T.-Y.; Yuan S.;Yu S.-L.;Chen H.-Y.;Hsu Y.-C.;Su K.-Y.;Chen H.-W.;Chen C.-Y.;Yu C.-J.;Jin-Yuan Shih;Chang Y.-L.;Cheng C.-L.;Hsu C.-P.;Hsia J.-Y.;Lin C.-Y.;Wu G.;Liu C.-H.;Wang C.-D.;Yang K.-C.;Chen Y.-W.;Lai Y.-L.;Hsu C.-C.;Lin T.-C.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Chen J.J.W.;Chang G.-C.;Li K.-C.;Yang P.-C.
臺大學術典藏	2020-08-13T06:33:49Z	Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer	Chang G.-C.; JIN-YUAN SHIH; Yu S.-L.; Yang P.-C.; Ho B.-C.; Chan W.-K.; Yang J.C.-H.; Kuo M.-L.; Su K.-Y.; Chen H.-Y.; Li K.-C.
臺大學術典藏	2020-08-13T06:33:43Z	Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan	Yang T.-Y.; Chiu K.-L.; Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; JIN-YUAN SHIH; Yu S.-L.
臺大學術典藏	2020-08-13T06:33:39Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Ho C.-C.;Jin-Yuan Shih;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:33Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Bai Y.-Y.; Chang Y.-L.; Hsieh M.-S.; Su K.-Y.; Tsai T.-H.; Lee J.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Lin C.-C.;Jin-Yuan Shih;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.
臺大學術典藏	2020-08-13T06:33:33Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Yang J.C.; Yu C.-J.; JIN-YUAN SHIH; Lin C.-C.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Chen K.-Y.; Liao W.-Y.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.
臺大學術典藏	2020-08-13T06:33:24Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Tsai T.-H.; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:24Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.
臺大學術典藏	2020-08-12T08:25:29Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Chang T.-H.; Tsai M.-F.; Su K.-Y.; SHANG-GIN WU; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-12T07:57:16Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.; Molina-Vila M.A.; SHENG-YUAN RUAN; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2020-08-12T06:34:47Z	R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability	Chen H.-Y.; Yu S.-L.; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; Chen H.-W.; Chen H.-Y.;Yu S.-L.;Ho B.-C.;Su K.-Y.;Hsu Y.-C.;Chang C.-S.;Li Y.-C.;Yang S.-Y.;Hsu P.-Y.;Ho H.;Chang Y.-H.;Chen C.-Y.;Yang H.-I.;Hsu C.-P.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Tseng J.-S.;Hsia J.-Y.;Chuang C.-Y.;Yuan S.;Lee M.-H.;Liu C.-H.;Wu G.-I.;Hsiung C.A.;Chen Y.-M.;Wang C.-L.;Huang M.-S.;Chong-Jen Yu;Chen K.-Y.;Tsai Y.-H.;Su W.-C.;Chen H.-W.;Chen J.J.W.;Chen C.-J.;Chang G.-C.;Yang P.-C.;Li K.-C.; Li K.-C.; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.
臺大學術典藏	2020-08-12T06:34:35Z	EGFR mutation, smoking, and gender in advanced lung adenocarcinoma	Yu S.-L.; Chen H.-W.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; CHONG-JEN YU; Ho C.-C.; Huang M.-S.; Tsai C.-M.; Yen S.H.; Chen C.-Y.; Wang C.-L.; Chen K.-C.; Hsu K.-H.; Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Chong-Jen Yu;Tsai Y.-H.;Chen J.-S.;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Liu T.-W.;Chang G.-C.; Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Chang G.-C.; Liu T.-W.
臺大學術典藏	2020-08-12T06:34:33Z	Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS	Yan B.-S.; Chiu H.-C.; CHONG-JEN YU; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; Yu S.-L.; Su K.-Y.; Su K.-Y.;Yan B.-S.;Chiu H.-C.;Chong-Jen Yu;Chang S.-Y.;Jou R.;Liu J.-L.;Hsueh P.-R.;Yu S.-L.
臺大學術典藏	2020-08-12T06:34:15Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2020-08-12T02:50:46Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Shih J.-Y.; CHAO-CHI HO; Yu K.-L.; Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2020-08-12T02:50:41Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2020-08-12T02:50:40Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.;Shih J.-Y.;Yu C.-J.;Chao-Chi Ho;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2020-08-12T02:50:36Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.
臺大學術典藏	2020-08-12T02:50:35Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.

Showing items 101-125 of 249 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2818675
	???header.visitor??? : 28215147 ???header.onlineuser??? : 624 ???header.sponsordeclaration???